According to Viatris's latest financial reports the company's current earnings (TTM) are $0.77 B. a decrease over its 2022 earnings that were of $3.40 B.The earnings displayed on this page is the company's Pretax Income.
Year | Earnings | Change |
---|---|---|
2023 | $0.77 B | -77.21% |
2022 | $3.40 B | -12176.6% |
2021 | -$28.2 M | -87.38% |
2020 | -$0.23 B | -133.26% |
2019 | $0.67 B | -20.1% |
2018 | $0.84 B | -41.52% |
2017 | $1.43 B | 149.37% |
2016 | $0.57 B | -54.06% |
2015 | $1.25 B | -4.05% |
2014 | $1.30 B | 23.29% |
2013 | $1.06 B | -4.69% |
2012 | $1.11 B | 12.35% |
2011 | $0.99 B | 44.1% |
2010 | $0.68 B | 26.02% |
2009 | $0.54 B | 65.39% |
2008 | $0.32 B | |
2006 | $0.43 B | 75.03% |
2005 | $0.24 B | -30.36% |
2004 | $0.35 B | -28.3% |
2003 | $0.49 B | 20.35% |
2002 | $0.41 B | 74.98% |
2001 | $0.23 B |
Company | Earnings | Earnings differencediff. | Country |
---|---|---|---|
OPKO Health
OPK | -$0.19 B | -123.75% | ๐บ๐ธ USA |
Onconova Therapeutics ONTX | -$18.95 M | -102.44% | ๐บ๐ธ USA |